Global Pharmacovigilance Market Research Report 2024(Status and Outlook)

Global Pharmacovigilance Market Research Report 2024(Status and Outlook)



Report Overview:

The Global Pharmacovigilance Market Size was estimated at USD 2754.20 million in 2023 and is projected to reach USD 4394.91 million by 2029, exhibiting a CAGR of 8.10% during the forecast period.

This report provides a deep insight into the global Pharmacovigilance market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmacovigilance Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmacovigilance market in any manner.

Global Pharmacovigilance Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Eli Lilly and Company

ICON

Elsevier

Chiltern

Atlantic Research Group

Mapi Group

Accenture

Clinquest Group

GSK

PRA Health Sciences

Market Segmentation (by Type)

Chemotherapy

Contract Outsourcing

Market Segmentation (by Application)

Pharma and Biotech Companies

Contract Research Organizations (CROs)

Business Process Outsourcing (BPO) Firms

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Pharmacovigilance Market

Overview of the regional outlook of the Pharmacovigilance Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacovigilance Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Pharmacovigilance
1.2 Key Market Segments
1.2.1 Pharmacovigilance Segment by Type
1.2.2 Pharmacovigilance Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Pharmacovigilance Market Overview
2.1 Global Market Overview
2.1.1 Global Pharmacovigilance Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmacovigilance Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Pharmacovigilance Market Competitive Landscape
3.1 Global Pharmacovigilance Sales by Manufacturers (2019-2024)
3.2 Global Pharmacovigilance Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmacovigilance Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmacovigilance Sales Sites, Area Served, Product Type
3.6 Pharmacovigilance Market Competitive Situation and Trends
3.6.1 Pharmacovigilance Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmacovigilance Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Pharmacovigilance Industry Chain Analysis
4.1 Pharmacovigilance Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Pharmacovigilance Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Pharmacovigilance Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacovigilance Sales Market Share by Type (2019-2024)
6.3 Global Pharmacovigilance Market Size Market Share by Type (2019-2024)
6.4 Global Pharmacovigilance Price by Type (2019-2024)
7 Pharmacovigilance Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacovigilance Market Sales by Application (2019-2024)
7.3 Global Pharmacovigilance Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmacovigilance Sales Growth Rate by Application (2019-2024)
8 Pharmacovigilance Market Segmentation by Region
8.1 Global Pharmacovigilance Sales by Region
8.1.1 Global Pharmacovigilance Sales by Region
8.1.2 Global Pharmacovigilance Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmacovigilance Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmacovigilance Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmacovigilance Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmacovigilance Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmacovigilance Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Eli Lilly and Company
9.1.1 Eli Lilly and Company Pharmacovigilance Basic Information
9.1.2 Eli Lilly and Company Pharmacovigilance Product Overview
9.1.3 Eli Lilly and Company Pharmacovigilance Product Market Performance
9.1.4 Eli Lilly and Company Business Overview
9.1.5 Eli Lilly and Company Pharmacovigilance SWOT Analysis
9.1.6 Eli Lilly and Company Recent Developments
9.2 ICON
9.2.1 ICON Pharmacovigilance Basic Information
9.2.2 ICON Pharmacovigilance Product Overview
9.2.3 ICON Pharmacovigilance Product Market Performance
9.2.4 ICON Business Overview
9.2.5 ICON Pharmacovigilance SWOT Analysis
9.2.6 ICON Recent Developments
9.3 Elsevier
9.3.1 Elsevier Pharmacovigilance Basic Information
9.3.2 Elsevier Pharmacovigilance Product Overview
9.3.3 Elsevier Pharmacovigilance Product Market Performance
9.3.4 Elsevier Pharmacovigilance SWOT Analysis
9.3.5 Elsevier Business Overview
9.3.6 Elsevier Recent Developments
9.4 Chiltern
9.4.1 Chiltern Pharmacovigilance Basic Information
9.4.2 Chiltern Pharmacovigilance Product Overview
9.4.3 Chiltern Pharmacovigilance Product Market Performance
9.4.4 Chiltern Business Overview
9.4.5 Chiltern Recent Developments
9.5 Atlantic Research Group
9.5.1 Atlantic Research Group Pharmacovigilance Basic Information
9.5.2 Atlantic Research Group Pharmacovigilance Product Overview
9.5.3 Atlantic Research Group Pharmacovigilance Product Market Performance
9.5.4 Atlantic Research Group Business Overview
9.5.5 Atlantic Research Group Recent Developments
9.6 Mapi Group
9.6.1 Mapi Group Pharmacovigilance Basic Information
9.6.2 Mapi Group Pharmacovigilance Product Overview
9.6.3 Mapi Group Pharmacovigilance Product Market Performance
9.6.4 Mapi Group Business Overview
9.6.5 Mapi Group Recent Developments
9.7 Accenture
9.7.1 Accenture Pharmacovigilance Basic Information
9.7.2 Accenture Pharmacovigilance Product Overview
9.7.3 Accenture Pharmacovigilance Product Market Performance
9.7.4 Accenture Business Overview
9.7.5 Accenture Recent Developments
9.8 Clinquest Group
9.8.1 Clinquest Group Pharmacovigilance Basic Information
9.8.2 Clinquest Group Pharmacovigilance Product Overview
9.8.3 Clinquest Group Pharmacovigilance Product Market Performance
9.8.4 Clinquest Group Business Overview
9.8.5 Clinquest Group Recent Developments
9.9 GSK
9.9.1 GSK Pharmacovigilance Basic Information
9.9.2 GSK Pharmacovigilance Product Overview
9.9.3 GSK Pharmacovigilance Product Market Performance
9.9.4 GSK Business Overview
9.9.5 GSK Recent Developments
9.10 PRA Health Sciences
9.10.1 PRA Health Sciences Pharmacovigilance Basic Information
9.10.2 PRA Health Sciences Pharmacovigilance Product Overview
9.10.3 PRA Health Sciences Pharmacovigilance Product Market Performance
9.10.4 PRA Health Sciences Business Overview
9.10.5 PRA Health Sciences Recent Developments
10 Pharmacovigilance Market Forecast by Region
10.1 Global Pharmacovigilance Market Size Forecast
10.2 Global Pharmacovigilance Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmacovigilance Market Size Forecast by Country
10.2.3 Asia Pacific Pharmacovigilance Market Size Forecast by Region
10.2.4 South America Pharmacovigilance Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmacovigilance by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Pharmacovigilance Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmacovigilance by Type (2025-2030)
11.1.2 Global Pharmacovigilance Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmacovigilance by Type (2025-2030)
11.2 Global Pharmacovigilance Market Forecast by Application (2025-2030)
11.2.1 Global Pharmacovigilance Sales (K Units) Forecast by Application
11.2.2 Global Pharmacovigilance Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings